IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Future Rare Diseases

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

0.70

h-Index

2023-2024

 3

Rank

2023-2024

 13043

SJR

2023-2024

 0.398

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Future Rare Diseases
Abbreviation Future Rare Dis.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q3)
h-index 3
Overall Rank/Ranking 13043
SCImago Journal Rank (SJR) 0.398
Impact Score 0.70
Publisher Taylor and Francis Ltd.
Country United Kingdom
ISSN 23995270
Best Quartile Q3
Coverage History 2021-2023




About Future Rare Diseases


Future Rare Diseases is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3). It is published by Taylor and Francis Ltd.. The overall rank of Future Rare Diseases is 13043. According to SCImago Journal Rank (SJR), this journal is ranked 0.398. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 3. The best quartile for this journal is Q3.

The ISSN of Future Rare Diseases journal is 23995270. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Future Rare Diseases is cited by a total of 23 articles during the last 3 years (Preceding 2023).


Future Rare Diseases Impact IF 2023-2024


The Impact IF 2023 of Future Rare Diseases is 0.70, which is computed in 2024 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Future Rare Diseases Impact IF 2024 Prediction


Impact IF 2023 of Future Rare Diseases is 0.70. If the same upward trend persists, Impact IF may rise in 2024 as well.


Impact IF Trend


Year wise Impact IF of Future Rare Diseases. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 0.70

Future Rare Diseases h-index


  Table Setting

Future Rare Diseases has an h-index of 3. It means 3 articles of this journal have more than 3 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Future Rare Diseases ISSN


The ISSN of Future Rare Diseases is 23995270. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Future Rare Diseases Rank and SCImago Journal Rank (SJR)


The overall rank of Future Rare Diseases is 13043. According to SCImago Journal Rank (SJR), this journal is ranked 0.398. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Future Rare Diseases by Year


Year SJR
2023/2024 Coming Soon
2023 0.398

Ranking of Future Rare Diseases by Year


Year Ranking
2023/2024 Coming Soon
2023 13043

Future Rare Diseases Publisher


Table Setting

Future Rare Diseases is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2021-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Future Rare Diseases is Future Rare Dis.. This abbreviation ('Future Rare Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Future Rare Diseases


If your research field is/are related to Medicine (miscellaneous) (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Future Rare Diseases?

Future Rare Diseases latest impact IF is 0.70. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.70 (2023) and 0.70 (2023), respectively, in the last 1 year. Moreover, its average IS is 0.7 in the previous 1 year.


What's the SCImago Journal Rank (SJR) of the Future Rare Diseases?

The Future Rare Diseases has an SJR (SCImago Journal Rank) of 0.398, according to the latest data. It is computed in the year 2024. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.398 in 2023 and the lowest being 0.398 in 2023. Furthermore, the average SJR of the Future Rare Diseases over the previous 1-year period stands at 0.7.


What's the latest h-index of the Future Rare Diseases?

The latest h-index of the Future Rare Diseases is 3.


Who's the publisher of the Future Rare Diseases?

The Future Rare Diseases is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Future Rare Diseases?

The Future Rare Diseases is currently ranked 13043 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 13043 in 2023 and its lowest position of 13043 in 2023.


What's the abbreviation or short name for the Future Rare Diseases?

The standard ISO4 abbreviation for the Future Rare Diseases is Future Rare Dis..


Is the "Future Rare Diseases" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Future Rare Diseases is classified as a journal that the Taylor and Francis Ltd. publishes.


What's the scope or major areas of the Future Rare Diseases?

The Future Rare Diseases encompasses the following areas:

  • Medicine (miscellaneous)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Future Rare Diseases?

The Future Rare Diseases is assigned the following International Standard Serial Numbers (ISSN): 23995270.


What's the best quartile of the Future Rare Diseases?

The best quartile for the Future Rare Diseases is Q3 (2023).


What's the coverage history of the Future Rare Diseases?

The Future Rare Diseases coverage history can be summarized as follows: 2021-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 10291 Springer Netherlands 30 2.62
Clinical Medicine and Research journal 14722 Marshfield Clinic 62 1.02
Milan Journal of Mathematics journal 3538 Birkhauser Verlag Basel 29 1.14
World Englishes journal 3418 Wiley-Blackwell 64 1.64
Abacus journal 5997 Wiley-Blackwell Publishing Ltd 53 2.75
British Journal of Special Education journal 16076 Wiley-Blackwell Publishing Ltd 44 0.78
Proteomics - Clinical Applications journal 9438 Wiley-VCH Verlag 64 2.28
Acta Periodica Technologica journal 23723 University of Novi Sad, Faculty of Technology 21 0.31
Contemporanea journal 24588 Societa Editrice Il Mulino 6 0.25
English Literary Renaissance journal 25777 University of Chicago Press 20 0.36

Check complete list




Year wise Impact Score (IS) of Future Rare Diseases

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 0.70



Top Journals/Conferences in Medicine (miscellaneous)

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Research | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

MMWR supplements
Epidemiology Program Office | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All